Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  29,954 results for ""Canagliflozin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

  • Authors : Cardoza K; Department of Medicine, Cedars-Sinai Medical Center, California, Los Angeles, USA.; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Canagliflozin*/Canagliflozin*/Canagliflozin*/adverse effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3530-3540. Date of Electronic Publication: 2024 Jun 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis.

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 4060-4068. Date of Electronic Publication: 2024 Jul 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Poly(allylamine)-adorned heptylcarboxymethyl galactomannan nanocarriers of canagliflozin for controlling type-2 diabetes: Optimization by Box-Behnken design and in vivo performance.

  • Authors : Yadav H; Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh 484887, India.; Maiti S

Subjects: Galactose*/Galactose*/Galactose*/chemistry ; Galactose*/Galactose*/Galactose*/analogs & derivatives ; Mannans*/Mannans*/Mannans*/chemistry

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 Oct; Vol. 277 (Pt 2), pp. 134253. Date of Electronic Publication: 2024 Jul 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation.

  • Authors : Li XC; Division of Pulmonary Medicine, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, Wenzhou, 325000, China.; Zhu XY

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/pharmacology ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Cell Proliferation*/Cell Proliferation*/Cell Proliferation*/drug effects

  • Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2024 Sep; Vol. 45 (9), pp. 1861-1878. Date of Electronic Publication: 2024 May 08.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin.

  • Authors : Miller RA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA. .; Geriatrics Center, University of Michigan, Ann Arbor, MI, USA. .

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/pharmacology ; Thiosulfates*/Thiosulfates*/Thiosulfates*/pharmacology ; Longevity*/Longevity*/Longevity*/drug effects

  • Source: GeroScience [Geroscience] 2024 Oct; Vol. 46 (5), pp. 4657-4670. Date of Electronic Publication: 2024 May 16.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Hypothalamic sex-specific metabolic shift by canagliflozin during aging.

  • Authors : Jayarathne HSM; Department of Biological Sciences, Integrative Biosciences Center, Wayne State University, Room 2418 IBio, 6135 Woodward, Detroit, MI, 48202, USA.; Sullivan R

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/pharmacology ; Aging*/Aging*/Aging*/metabolism ; Hypothalamus*/Hypothalamus*/Hypothalamus*/metabolism

  • Source: GeroScience [Geroscience] 2024 Oct; Vol. 46 (5), pp. 4479-4493. Date of Electronic Publication: 2024 May 27.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT2 inhibitor canagliflozin reduces visceral adipose tissue in db/db mice by modulating AMPK/KLF4 signaling and regulating mitochondrial dynamics to induce browning.

  • Authors : Qu J; NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, 300134, People's Republic of China.; Tian L

Subjects: Kruppel-Like Factor 4* ; Mitochondrial Dynamics*/Mitochondrial Dynamics*/Mitochondrial Dynamics*/drug effects ; Canagliflozin*/Canagliflozin*/Canagliflozin*/pharmacology

  • Source: Molecular and cellular endocrinology [Mol Cell Endocrinol] 2024 Oct 01; Vol. 592, pp. 112320. Date of Electronic Publication: 2024 Jul 03.Publisher: North Holland Publishing Country of Publication: Ireland NLM ID: 7500844 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of canagliflozin on kidney oxygenation evaluated using blood oxygenation level-dependent MRI in patients with type 2 diabetes.

  • Authors : Mori K; Department of Nephrology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Inoue T

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Aug 30; Vol. 15, pp. 1451671. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study.

  • Authors : Isogawa M; Institute for Clinical and Translational Science, Nara Medical University Hospital, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.; Makino H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Thiazolidines*/Thiazolidines*/Thiazolidines*/therapeutic use

  • Source: BMC endocrine disorders [BMC Endocr Disord] 2024 Aug 19; Vol. 24 (1), pp. 153. Date of Electronic Publication: 2024 Aug 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

Record details

Read More Add to Saved list
×
Academic Journal

Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation.

  • Authors : Khamies SM; Faculty of Pharmacy, Department of Pharmacology and Toxicology, Menoufia University, Menoufia, 32511, Egypt.; El-Yamany MF

Subjects: Streptozocin*/Streptozocin*/Streptozocin*/toxicity ; Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism

  • Source: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2024 Jul 29; Vol. 19 (1), pp. 39. Date of Electronic Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101256586 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  29,954 results for ""Canagliflozin""